| Filed On | Filing |
|---|---|
| 12 Nov 2004 | Form 3/A: Schlotterbeck David L, Chmn & CEO-Clncl. Techn & Svcs |
| 20 Apr 2004 |
Form 3/A: Parrish Mark W, EVP-Group Pres., Pharm. Dist.
Holds 143 shares of Common Shares |
Loading...